|
Clinical Trials and Observations
Citations 231-240 of 2742 total displayed.
|
Past content
(since May 1998):
|
Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F
- Franz X. Schaub, Roland Jäger, Renate Looser, Hui Hao-Shen, Sylvie Hermouet, François Girodon, Andre Tichelli, Heinz Gisslinger, Robert Kralovics, and Radek C. Skoda
Blood 2009; 113: 2022-2027.
[Abstract]
[Full text]
[PDF]
Effect of elevated levels of coagulation factors on the risk of venous thrombosis in long-distance travelers
- Saskia Kuipers, Suzanne C. Cannegieter, Carine J. M. Doggen, and Frits R. Rosendaal
Blood 2009; 113: 2064-2069.
[Abstract]
[Full text]
[PDF]
Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes
- Yachiyo Kuwatsuka, Koichi Miyamura, Ritsuro Suzuki, Masaharu Kasai, Atsuo Maruta, Hiroyasu Ogawa, Ryuji Tanosaki, Satoshi Takahashi, Kyuhei Koda, Kazuhiro Yago, Yoshiko Atsuta, Takashi Yoshida, Hisashi Sakamaki, and Yoshihisa Kodera
Blood 2009; 113: 2096-2103.
[Abstract]
[Full text]
[PDF]
Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia
- Yoshiko Atsuta, Ritsuro Suzuki, Tokiko Nagamura-Inoue, Shuichi Taniguchi, Satoshi Takahashi, Shunro Kai, Hisashi Sakamaki, Yasushi Kouzai, Masaharu Kasai, Takahiro Fukuda, Hiroshi Azuma, Minoko Takanashi, Shinichiro Okamoto, Masahiro Tsuchida, Keisei Kawa, Yasuo Morishima, Yoshihisa Kodera, Shunichi Kato, and for the Japan Marrow Donor Program and the Japan Cord Blood Bank Network
Blood 2009; 113: 1631-1638.
[Abstract]
[Full text]
[PDF]
Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors
- Masako Iwanaga, Masuko Tagawa, Kunihiro Tsukasaki, Tatsuki Matsuo, Ken-ichi Yokota, Yasushi Miyazaki, Takuya Fukushima, Tomoko Hata, Yoshitaka Imaizumi, Daisuke Imanishi, Jun Taguchi, Sabro Momita, Shimeru Kamihira, and Masao Tomonaga
Blood 2009; 113: 1639-1650.
[Abstract]
[Full text]
[PDF]
Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients
- Raffaella Fontana, Marco Bregni, Arcadi Cipponi, Laura Raccosta, Cristina Rainelli, Daniela Maggioni, Francesca Lunghi, Fabio Ciceri, Sylvain Mukenge, Claudio Doglioni, Didier Colau, Pierre G. Coulie, Claudio Bordignon, Catia Traversari, and Vincenzo Russo
Blood 2009; 113: 1651-1660.
[Abstract]
[Full text]
[PDF]
Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century
- Dianne Pulte, Adam Gondos, and Hermann Brenner
Blood 2009; 113: 1408-1411.
[Abstract]
[Full text]
[PDF]
Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy
- Tim M. Illidge, Mike Bayne, Nicholas S. Brown, Samantha Chilton, Mark S. Cragg, Martin J. Glennie, Yong Du, Valerie Lewington, James Smart, James Thom, Maureen Zivanovic, and Peter W. M. Johnson
Blood 2009; 113: 1412-1421.
[Abstract]
[Full text]
[PDF]
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation
- Asad Bashey, Bridget Medina, Sue Corringham, Mildred Pasek, Ewa Carrier, Linda Vrooman, Israel Lowy, Scott R. Solomon, Lawrence E. Morris, H. Kent Holland, James R. Mason, Edwin P. Alyea, Robert J. Soiffer, and Edward D. Ball
Blood 2009; 113: 1581-1588.
[Abstract]
[Full text]
[PDF]
Clinical relevance of decreased free protein S levels: results from a retrospective family cohort study involving 1143 relatives
- Willem M. Lijfering, Rene Mulder, Min Ki ten Kate, Nic J. G. M. Veeger, Andre B. Mulder, and Jan van der Meer
Blood 2009; 113: 1225-1230.
[Abstract]
[Full text]
[PDF]
|
|
